Video News from the 2009 International Conference on Alzheimer's Disease (ICAD)

Article

Each morning at the 2009 ICAD conference, there is a media session featuring researchers who will be speaking or presenting that day. The session is recorded and posted online as brief videos. The theme for the Monday session was “Risk Factors for Alzheimer's; Update on Alzheimer's Prevalence/Incidence.”

Each morning at the 2009 ICAD conference, there is a media session featuring researchers who will be speaking or presenting that day. The session is recorded and posted online as brief videos. The theme for the Monday session was “Risk Factors for Alzheimer's; Update on Alzheimer's Prevalence/Incidence.”

Ugo Lucca, MSc, head of the Laboratory of Geriatric Neuropsychiatry at the Mario Negri Institute for Pharmacological Research, a non-profit biomedical research foundation in Milan, Italy. Lucca spoke about the Monzino 80-Plus Study, which focused on the rise in risk of dementia faced by “the oldest of the old.”

Click here to watch the video.

Colleen Jackson, a doctoral student in clinical psychology, with a concentration on neuropsychology, at the University of Connecticut. Jackson spoke about the public’s lack of awareness and understanding of known risk factors for Alzheimer’s disease.

Click here to watch the video.

Kaycee Sink, MD, assistant professor of medicine, Department of Medicine, Section of Gerontology and Geriatric Medicine, and director of the Kulynych Memory Assessment Clinic at Wake Forest University School of Medicine. Sink discussed results from the Ginkgo Evaluation of Memory Study (GEMS), which showed that moderate alcohol intake is associated with lower dementia incidence.

Click here to watch the video.

Additional video footage from Monday, including a Q&A press briefing with assembled members of the media, is available here.

Related Videos
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Ryan McLaughlin, PhD: Challenges Studying Cannabis to Treat Psychiatric Illness
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Charles R. Marmar, MD: Blood Biomarkers for PTSD
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
Andrew Chen, MD: Taking More Adverse Event Prone Anxiety Medications
© 2024 MJH Life Sciences

All rights reserved.